TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
Completed

Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease

The cause of Parkinson's disease (PD) is unknown and a reliable biomarker to identify PD patients as early as possible is urgently needed. Nerve cells near the nose and in the gut become first affected in PD and patients frequently suffer f

Espoo, Finland+4 moreView details
TerminatedN/A

Intravenous Versus Inhalational Anesthesia in Parkinson's Disease

Parkinson's disease is a common progressive degenerative disease affecting 3% of all patients over the age of 65. Given their age and frailty, these patients frequently require surgical procedures with general anesthesia.

New York, New York, United StatesView details
CompletedPhase 3

A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease

The purpose of this trial is to assess whether it is possible for subjects with idiopathic Parkinson's Disease to switch from ropinirole, pramipexole and cabergoline to rotigotine transdermal system (SPM 962) overnight without worsening of

RTP, North Carolina, United StatesView details
UnknownPhase 3

Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease

Lingzhi(Ganoderma) is widely used in traditional Chinese medicine. Previous studies indicated that Lingzhi was safe, well tolorated, and improved symptoms as an add-on therapy to levodopa in early Parkinson's disease(PD) patients.

Beijing, Beijing Municipality, ChinaView details
RecruitingN/A

Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease

Parkinson's disease (PD) is a progressive neurodegenerative disorder commonly associated with gait disturbances, balance impairments, and freezing of gait, which significantly increase the risk of falls and reduce functional independence. C

Lahore, Punjab Province, PakistanView details
UnknownN/A

Deep Brain Stimulation on Dual-task Gait Performance in PD

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. Motor symptoms include rigidity, bradykinesia, tremor, and postural instability, these motor symptoms can cause gait dysfunction.

Taipei, TaiwanView details
Completed

Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS

Changes in deep brain stimulation (DBS) settings can have a delayed effect on gait function, which makes it impractical to optimize DBS for gait parameters in the clinic. Wearable movement sensors could be used to assess gait impairment in

Cincinnati, Ohio, United States+1 moreView details
UnknownEARLY_Phase 1

A Study on the Treatment of Parkinson's Disease With Autologous Neural Stem Cells

This is a single center, single arm and open-label study to investigate the safety and efficacy of iPS-NCS with Parkinson's Disease

Multiple locationsView details
CompletedPhase 1

A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients

In this Phase I/IIa study, the effect of continuous subcutaneous administration of LD/CD solution (ND0612) on the safety and PK profile of LD will be examined.

Jerusalem, IsraelView details
Completed

Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath

Parkinson's disease is diagnosed clinically, because biomarkers that may help in diagnosis and differential diagnosis are not yet available. Exhaled breath testing may yield a "breath-print" that can be used to distinguish healthy and disea

Multiple locationsView details
CompletedN/A

e-Mobile Tablet for People With Chronic Conditions

Maintaining a healthy diet and engaging in routine physical activity may help decrease severity of symptoms, prevent secondary conditions, and slow functional decline in people with disabling neuromusculoskeletal conditions. However, people

Cleveland, Ohio, United StatesView details
RecruitingN/A

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

α-Synucleinopathies, including Parkinson's disease and dementia with Lewy bodies, are the second most common neurodegenerative diseases. In addition to progressive motor deterioration, cognitive decline is a key element of the non-motor sym

Bonn, North Rhine West-Falia, GermanyView details
CompletedPhase 2

A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

This is a phase 2 study designed to assess the safety, tolerability and efficacy of NLY01 in subjects with early untreated Parkinson's disease (PD). Evidence suggests NLY01, a pegylated form of exenatide, may be beneficial in PD and is bein

Birmingham, Alabama, United States+60 moreView details
CompletedPhase 2

A Trial of MitoQ for the Treatment of People With Parkinson's Disease

In Parkinson's Disease, the mitochondrial membranes in cells that produce dopamine become damaged by oxidants, leading to the death of these cells and progressive tremor, slowness of movement and the loss of neurons in the substantia nigra

Sydney, New South Wales, Australia+12 moreView details
Recruiting

Pathways Mediating Impaired Postural Control in Parkinson's Disease

The purpose of this project is to use transcranial magnetic stimulation (TMS) to explore the state of excitability of corticocortical and corticofugal (cortex to spinal cord, cortex to brainstem to spinal cord) pathways that project to musc

Minneapolis, Minnesota, United StatesView details
RecruitingN/A

Evaluation of the Safety of Electrical Spinal Cord Stimulation in Parkinson's Patients Presenting With Painful Camptocormia

Camptocormia is defined by abnormal flexion of the trunk, not fixed, present when standing and walking, resolves when lying down and often complicated by lower back pain. It can be observed in numerous neurological pathologies with a preval

Amiens, France+3 moreView details
TerminatedN/A

Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism

Parkinson's disease (PD) is the second most common neurodegenerative disorder of the elderly that affects a million patients in US. Sleep dysfunction impacts up to 90% of PD patients.

Chicago, Illinois, United StatesView details
Completed

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

The primary objective of this study was to describe neurologists' population of patients treated with pramipexole and suffering from Parkinson's disease (so called 'primary care' population). The secondary objectives were: * Evaluate the m

Multiple locationsView details
CompletedPhase 2

Masked Faces in Parkinson Disease: Mechanism and Treatment

The purpose of this study is to examine the effectiveness of high intensity respiratory muscle strength training in treating blunted facial expression in people with Parkinson disease.

Gainesville, Florida, United StatesView details
Terminated

Genetics of Motor Learning

Background: \- New studies in human genetics have revealed information about genetic connections to memory and motor behavior. Researchers are interested in investigating the role of genetics in motor learning, in conjunction with related

Bethesda, Maryland, United StatesView details
Load more trials